Summary: Retatrutide commonly causes bowel changes including diarrhoea, constipation, and abdominal discomfort due to its activation of GLP-1 receptors throughout the gastrointestinal tract, which alters gut motility
Patients with type 2 diabetes may have additional risk factors for tinnitus
Even if you acknowledge the limitations of the data (insulin as a comparison, we cant review the full paper yet), a finding like fewer deaths is always a positive sign, and its an endpoint thats impossible to achieve with a placebo effect or manipulate with selective criteria
The duration of fatigue associated with GLP-1 medications varies considerably between individuals, but there are recognisable patterns that can help set realistic expectations
It follows a once-weekly injection schedule with a gradual step-up approach, starting low and increasing every few weeks to help your body adjust